Investing

3 Surprising Overlooked Stocks That Could Have Big Upside

Allscripts

This is another health care stock that the buy side in not very enamored with. Wall Street firms also have more Neutral than Buy ratings on the stock. Allscripts is a leader in health care information technology solutions that advance clinical, financial and operational results. The company’s solutions connect people, places and data across an open, connected community of health. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Some Wall Street analysts have cited limited growth prospects for the stock, and it is viewed by others as a turnaround story that has a long way to go. Analysts disagree with management’s strategy of maintaining the company’s core EHR systems provider branding. Instead, they suggest that increasing focus on population health and patient portals could be a better path forward.

The consensus price target is posted at $14.43, and the stock closed Friday at $14.59 per share.

Vantiv

This company has a reasonably solid following on Wall Street, with more Buy ratings than Neutral, but according to the report it is very out of consensus with Wall Street firms. Vantiv is a leading provider of payment processing services and related technology solutions for merchants and financial institutions of all sizes

Vantiv acquisitions have vaulted it to the second slot among the nation’s largest payment processors. The company had been the third-largest processor the prior year, but it cranked out 28% growth in the number of merchant transactions it processed last year, according to a recent Nilson Report. Vantiv processed 15.5 billion purchase transactions last year. It jumped ahead of Bank of America by more than a billion transactions, but Vantiv still trails front-running First Data.

The analysts’ consensus price target is $40.71, and the shares ended last week at $39.06 apiece.

ALSO READ: 5 Stocks That Generate the Highest Free Cash Flow Yield

The distinct advantage of buying solid out-of-consensus stocks is they can still do very well. The ideal scenario is they continue to do well, and then all of a sudden they come back into consensus. Then some real money can be made as the Wall Street bandwagon hops aboard.

Sponsored: Find a Qualified Financial Advisor:

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.